Clinical Trial Update: Immunoglobulin G Therapy Dose Optimization

View source ↗

Summary

A completed Rutgers-sponsored clinical trial evaluating dose optimization of immunoglobulin G therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunodeficiency
• Obesity

Drugs mentioned

• Intravenous immunoglobulin (IVIG) therapy (immunoglobulin G)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Obesity, Immune Deficiency | Status: COMPLETED